To find out efficacy of 50 Millesimal potency in cases of leucorrhea

Efficacy of 50 millesimal scale in the treatment of leucorrhoea in reproductive age group

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/08/056797

Enrollment

100

Registered

2023-08-23

Start date

Unknown

Completion date

Unknown

Last updated

2023-09-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B955- Unspecified streptococcus as the cause of diseases classified elsewhere

Interventions

Intervention1: not applicable: not applicable Intervention2: Constitutional Homoeopathic Medicine: In each and all case will prescribe 50 Millesimal potency, oral route, selected medicine will give on

Eligibility

Inclusion criteria

Inclusion criteria: Age Group of 18-45 Female -Cases leucorrhea only

Exclusion criteria

Exclusion criteria: Patients on homoeopathic treatment for any other chronic diseases will be excluded. Antenatal & postnatal females Patients having any other chronic degenerative diseases Patient having Severe PID or any pelvic pathology.

Design outcomes

Primary

Measure	Time frame
The outcomes of the study will be measured in terms of clinical signs - per vaginal examination and symptoms Pap smear test in required cases microbiological improvement. amount of discharge duration of interval itching or notTimepoint: 4 weeks	—

Secondary

Measure	Time frame
To evaluate the safety tolerability of the formulation in patient suffering from LeucorrheaTimepoint: 4 weeks	—

Countries

India

Contacts

Public ContactFalguni Pilot

Paruluniversity

kamlesh.shah27300@paruluniversity.ac.in09426315845

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026